BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 36268762)

  • 1. Efficient one-pot synthesis of arylated pyrazole-fused pyran analogs: as leads to treating diabetes and Alzheimer's disease.
    Hameed S; Babatunde O; Salar U; Jabbar A; Chigurupati S; Solangi M; Atta L; Ul-Haq Z; Saleem F; Bhatia S; Al-Harrasi A; Taha M; Khan KM
    Future Med Chem; 2022 Nov; 14(21):1507-1526. PubMed ID: 36268762
    [No Abstract]   [Full Text] [Related]  

  • 2. Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer's disease: In vitro studies against yeast α-glucosidase, acetylcholinesterase and butyrylcholinesterase.
    Riaz S; Khan IU; Bajda M; Ashraf M; Qurat-Ul-Ain ; Shaukat A; Rehman TU; Mutahir S; Hussain S; Mustafa G; Yar M
    Bioorg Chem; 2015 Dec; 63():64-71. PubMed ID: 26451651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of synthetic 2-aryl quinoxaline derivatives as α-amylase, α-glucosidase, acetylcholinesterase, and butyrylcholinesterase inhibitors.
    Hameed S; Khan KM; Taslimi P; Salar U; Taskin-Tok T; Kisa D; Saleem F; Solangi M; Ahmed MHU; Rani K
    Int J Biol Macromol; 2022 Jun; 211():653-668. PubMed ID: 35568155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multitargeted inhibition of key enzymes associated with diabetes and Alzheimer's disease by 1,3,4-oxadiazole derivatives: Synthesis, in vitro screening, and computational studies.
    Fatima B; Saleem F; Salar U; Chigurupati S; Felemban SG; Ul-Haq Z; Tariq SS; Almahmoud SA; Taha M; Shah STA; Khan KM
    Arch Pharm (Weinheim); 2023 Dec; 356(12):e2300384. PubMed ID: 37806747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of δ-sultone-fused pyrazoles for treating Alzheimer's disease: Design, synthesis, biological evaluation and SAR studies.
    Xu Y; Zhang Z; Jiang X; Chen X; Wang Z; Alsulami H; Qin HL; Tang W
    Eur J Med Chem; 2019 Nov; 181():111598. PubMed ID: 31415981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dihydroquinazolin-4(1H)-one derivatives as novel and potential leads for diabetic management.
    Babatunde O; Hameed S; Salar U; Chigurupati S; Wadood A; Rehman AU; Venugopal V; Khan KM; Taha M; Perveen S
    Mol Divers; 2022 Apr; 26(2):849-868. PubMed ID: 33650031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of benzotriazoles derivatives and their dual potential as α-amylase and α-glucosidase inhibitors in vitro: Structure-activity relationship, molecular docking, and kinetic studies.
    Hameed S; Kanwal ; Seraj F; Rafique R; Chigurupati S; Wadood A; Rehman AU; Venugopal V; Salar U; Taha M; Khan KM
    Eur J Med Chem; 2019 Dec; 183():111677. PubMed ID: 31514061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicomponent diastereoselective synthesis of tetrahydropyridines as α-amylase and α-glucosidase enzymes inhibitors.
    Saleem F; Shamim F; Özil M; Baltaş N; Salar U; Ashraf S; Ul-Haq Z; Taha M; Solangi M; Khan KM
    Future Med Chem; 2023 Aug; 15(15):1343-1368. PubMed ID: 37650736
    [No Abstract]   [Full Text] [Related]  

  • 9. 2-Furoic piperazide derivatives as promising drug candidates of type 2 diabetes and Alzheimer's diseases: In vitro and in silico studies.
    Abbasi MA; Hassan M; Ur-Rehman A; Siddiqui SZ; Hussain G; Shah SAA; Ashraf M; Shahid M; Seo SY
    Comput Biol Chem; 2018 Dec; 77():72-86. PubMed ID: 30245349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and cholinesterase inhibition assay of liquiritigenin derivatives as anti-Alzheimer's activity.
    Guan L; Peng D; Zhang L; Jia J; Jiang H
    Bioorg Med Chem Lett; 2021 Nov; 52():128306. PubMed ID: 34371131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and Microwave-Assisted Synthesis of Aza-Resveratrol Analogs with Potent Cholinesterase Inhibition.
    Biscussi B; Richmond V; Baier CJ; Mañez PA; Murray AP
    CNS Neurol Disord Drug Targets; 2020; 19(8):630-641. PubMed ID: 32888280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, Synthesis and Biological Evaluation of New Cycloalkyl Fused Quinolines Tethered to Isatin Schiff Bases as Cholinesterase Inhibitors.
    Macha B; Kulkarni R; Garige AK; Palabindala R; Akkinepally R; Garlapati A
    Comb Chem High Throughput Screen; 2022; 25(1):167-186. PubMed ID: 33308120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly functionalized 2-amino-4H-pyrans as potent cholinesterase inhibitors.
    Kumar RS; Almansour AI; Arumugam N; Al-Thamili DM; Basiri A; Kotresha D; Manohar TS; Venketesh S; Asad M; Asiri AM
    Bioorg Chem; 2018 Dec; 81():134-143. PubMed ID: 30121001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New cholinesterase inhibitors for Alzheimer's disease: Structure activity relationship, kinetics and molecular docking studies of 1-butanoyl-3-arylthiourea derivatives.
    Larik FA; Shah MS; Saeed A; Shah HS; Channar PA; Bolte M; Iqbal J
    Int J Biol Macromol; 2018 Sep; 116():144-150. PubMed ID: 29729344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of Benzimidazole-Based Analogs as Anti Alzheimer's Disease Compounds and Their Molecular Docking Studies.
    Adalat B; Rahim F; Taha M; Alshamrani FJ; Anouar EH; Uddin N; Shah SAA; Ali Z; Zakaria ZA
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33092223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, biological evaluation, and molecular dynamics of novel cholinesterase inhibitors as anti-Alzheimer's agents.
    Shamsimeymandi R; Pourshojaei Y; Eskandari K; Mohammadi-Khanaposhtani M; Abiri A; Khodadadi A; Langarizadeh A; Sharififar F; Amirheidari B; Akbarzadeh T; Lotfian H; Foroumadi A; Asadipour A
    Arch Pharm (Weinheim); 2019 Jul; 352(7):e1800352. PubMed ID: 31136018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and Molecular Docking of New Bis-Thiazolidinone-Based Chalcone Analogs as Effective Inhibitors of Acetylcholinesterase and Butyrylcholinesterase.
    Hussain R; Rahim F; Rehman W; Taha M; Khan S; Zaman K; Adnan Ali Shah S; Wadood A; Imran S; Abdellatif MH
    Chem Biodivers; 2022 Oct; 19(10):e202200323. PubMed ID: 35997224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrazinyl thiazole linked indenoquinoxaline hybrids: Potential leads to treat hyperglycemia and oxidative stress; Multistep synthesis, α-amylase, α-glucosidase inhibitory and antioxidant activities.
    Hameed S; Khan KM; Salar U; Özil M; Baltaş N; Saleem F; Qureshi U; Taha M; Ul-Haq Z
    Int J Biol Macromol; 2022 Nov; 221():1294-1312. PubMed ID: 36113601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flavonols and 4-thioflavonols as potential acetylcholinesterase and butyrylcholinesterase inhibitors: Synthesis, structure-activity relationship and molecular docking studies.
    Mughal EU; Sadiq A; Ashraf J; Zafar MN; Sumrra SH; Tariq R; Mumtaz A; Javid A; Khan BA; Ali A; Javed CO
    Bioorg Chem; 2019 Oct; 91():103124. PubMed ID: 31319297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syntheses, in vitro α-amylase and α-glucosidase dual inhibitory activities of 4-amino-1,2,4-triazole derivatives their molecular docking and kinetic studies.
    Yeye EO; Kanwal ; Mohammed Khan K; Chigurupati S; Wadood A; Ur Rehman A; Perveen S; Kannan Maharajan M; Shamim S; Hameed S; Aboaba SA; Taha M
    Bioorg Med Chem; 2020 Jun; 28(11):115467. PubMed ID: 32327353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.